http://www.marketwatch.com/story/ap-pharma-sinks-medicines-co-gains-2010-03-19?reflink=MW_news_stmp
"U.S. Food and Drug Administration has informed the company it will not approve APF350 for the treatment of chemotherapy-induced nausea until more supporting information is provided."
http://www.thestreet.com/story/10707025/1/ap-pharma-netlist-early-volume-plays.html?cm_ven=GOOGLEFI
"A.P. Pharma (APPA) dropped by $1.08, or 52.7%, to 97 cents after the Food and Drug Administration did not approve its experimental drug APF530 for the treatment of nausea and vomiting induced by chemotherapy. The FDA said it found deficiencies in A.P.'s manufacturing facilities, and that more supporting information is needed. Volume topped 9.61 million shares, compared to the 50-day average daily volume of 658,000, according to the Nasdaq."
都可以看到FDA說需要更多資訊，請問一般的case都是這樣嗎？
我的意思是，FDA沒核准新藥時都會說"需要更多資料"？
還是真的APPA只要後來提供足夠資料就會有機會過？
這才是賭博呀...
ckkc wrote:
大大請節哀.最新的消...(恕刪)
這很正常
美股都晚上開
所以昨天就先掛PALM平盤價在那等
哪知一開盤就重挫
不過買到開盤價 以為算不錯
啊知~~開始慢慢往下滑
尾盤重挫接近30%
一天就損失近13%
幸好的是資金控管得宜
只用小資金進場
不然可能就被一拳擊倒在地爬不起來了
內文搜尋
從 APP 打開
X